KK

Kulvinder Kaur

Active Director Additional Director DIN 11302260
DIN 11302260 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Kulvinder Kaur

Data last updated:

Kulvinder Kaur is an Additional Director at Sysmed Biotech Private Limited (since 2025). The company operates in Pharma. Sysmed Biotech Private Limited reported revenue of ₹1.93 Cr (FY 2025).

DIN 11302260
Primary Designation Additional Director
Industry Pharma
First Appointment 17 Sep 2025
Largest company Sysmed Biotech Private Limited · ₹1.93 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sysmed Biotech Private Limited U51909GJ2021PTC127755
Additional Director17 Sep 2025₹1.93 Cr (FY 2025)Active

Board colleagues of Kulvinder Kaur

Directorship timeline

Open interactive timeline →
Sysmed Biotech Private Limited
Premium access

Shareholding and investment profile for Kulvinder Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kulvinder Kaur

Kulvinder Kaur currently holds 1 directorship: Sysmed Biotech Private Limited (Additional Director, since 17 Sep 2025, revenue ₹1.93 Cr (FY 2025)).

Kulvinder Kaur was first appointed on 17 Sep 2025 as Additional Director at Sysmed Biotech Private Limited.

The current boards of Kulvinder Kaur's companies include Laveena Arora (Sysmed Biotech Private Limited), Mandeep Kaur Channa (Sysmed Biotech Private Limited), Neelam Lalit Kapoor (Sysmed Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available